David Bodensteiner

2.6k total citations · 1 hit paper
35 papers, 1.7k citations indexed

About

David Bodensteiner is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, David Bodensteiner has authored 35 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 8 papers in Oncology and 7 papers in Immunology. Recurrent topics in David Bodensteiner's work include Platelet Disorders and Treatments (9 papers), Complement system in diseases (6 papers) and Blood groups and transfusion (6 papers). David Bodensteiner is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Complement system in diseases (6 papers) and Blood groups and transfusion (6 papers). David Bodensteiner collaborates with scholars based in United States, China and France. David Bodensteiner's co-authors include Nita L. Seibel, Thomas J. Walsh, Richard N. Greenberg, Mindy G. Schuster, Stephen Dummer, John S. Holcenberg, Robert W. Finberg, William E. Dismukes, Peter G. Pappas and Cindy L. Schwartz and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

David Bodensteiner

35 papers receiving 1.6k citations

Hit Papers

Liposomal Amphotericin B for Empirical Therapy in Patient... 1999 2026 2008 2017 1999 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
    1999 884 citations Thomas J. Walsh, Robert W. Finberg et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Bodensteiner United States 18 866 771 363 334 220 35 1.7k
U. Jehn Germany 24 498 0.6× 569 0.7× 827 2.3× 1.1k 3.2× 429 1.9× 125 2.7k
Hamdi Akan Türkiye 26 602 0.7× 775 1.0× 555 1.5× 471 1.4× 168 0.8× 106 1.8k
Martin Schmidt‐Hieber Germany 26 509 0.6× 766 1.0× 629 1.7× 567 1.7× 240 1.1× 59 2.0k
Subhash Varma India 20 570 0.7× 409 0.5× 191 0.5× 321 1.0× 161 0.7× 173 1.8k
Anna Candoni Italy 31 926 1.1× 955 1.2× 804 2.2× 1.1k 3.4× 162 0.7× 153 3.5k
Steve Trifilio United States 11 507 0.6× 447 0.6× 309 0.9× 262 0.8× 167 0.8× 16 1.2k
Gloria Mattiuzzi United States 17 882 1.0× 896 1.2× 356 1.0× 161 0.5× 30 0.1× 36 1.4k
Lambert F. R. Span Netherlands 20 708 0.8× 675 0.9× 152 0.4× 121 0.4× 141 0.6× 45 1.4k
Nicole M. A. Blijlevens Netherlands 28 477 0.6× 589 0.8× 711 2.0× 387 1.2× 418 1.9× 75 2.1k
Carola Arndt United States 23 820 0.9× 743 1.0× 753 2.1× 266 0.8× 82 0.4× 41 2.5k

Countries citing papers authored by David Bodensteiner

Since Specialization
Citations

This map shows the geographic impact of David Bodensteiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bodensteiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bodensteiner more than expected).

Fields of papers citing papers by David Bodensteiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Bodensteiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bodensteiner. The network helps show where David Bodensteiner may publish in the future.

Co-authorship network of co-authors of David Bodensteiner

This figure shows the co-authorship network connecting the top 25 collaborators of David Bodensteiner. A scholar is included among the top collaborators of David Bodensteiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bodensteiner. David Bodensteiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Reddy, Pavan S., et al.. (2004). Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura. Annals of Hematology. 84(4). 232–235. 54 indexed citations
5.
Zeigler, Zella R., Richard K. Shadduck, Jeffrey Gryn, et al.. (2001). Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP). Journal of Clinical Apheresis. 16(1). 19–22. 100 indexed citations
6.
Walsh, Thomas J., Robert W. Finberg, Carola Arndt, et al.. (1999). Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia. New England Journal of Medicine. 340(10). 764–771. 884 indexed citations breakdown →
7.
Zeigler, Zella R., John Lister, Jane M. Raymond, et al.. (1998). Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation. American Journal of Hematology. 59(1). 9–14. 19 indexed citations
8.
Veldhuizen, Peter J. Van, James R. Neff, Mark D. Murphey, David Bodensteiner, & Barry Skikne. (1993). Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. American Journal of Hematology. 44(4). 243–248. 96 indexed citations
9.
Bodensteiner, David & Gary C. Doolittle. (1993). Adverse Haematological Complications of Anticancer Drugs. Drug Safety. 8(3). 213–224. 16 indexed citations
10.
Bodensteiner, David, et al.. (1993). Effect of age on survival in acute leukemia: 1950–1990. Cancer. 72(5). 1602–1606. 20 indexed citations
11.
Bayer, William L., David Bodensteiner, Lowell Tilzer, & Mary G. Adams. (1992). Use of Platelets and Other Transfusion Products in Patients with Malignancy. Seminars in Thrombosis and Hemostasis. 18(4). 380–391. 16 indexed citations
12.
Bodensteiner, David, et al.. (1992). Disseminated Histoplasmosis in Patients With AIDS. Southern Medical Journal. 85(12). 1166–1170. 31 indexed citations
13.
Doolittle, Gary C., David Bodensteiner, Barry Skikne, & Mammo Amare. (1991). Therapy of aplastic anemia with sequential antithymocyte globulin and cyclosporin. American Journal of Hematology. 36(2). 144–146. 4 indexed citations
14.
Bodensteiner, David, et al.. (1991). Flow Cytometry of Needle Aspirates From Bone and Soft Tissue Tumors. Southern Medical Journal. 84(12). 1451–1454. 6 indexed citations
15.
Bodensteiner, David. (1990). Leukocyte depletion filters: A comparison of efficiency. American Journal of Hematology. 35(3). 184–186. 22 indexed citations
16.
Thomas, James H., et al.. (1989). Primary hypercoagulable states in general and vascular surgery. The American Journal of Surgery. 158(6). 491–494. 3 indexed citations
17.
Bodensteiner, David & Craig S. Rosenfeld. (1988). Elevated Platelet-Surface-Bound IgM in Thrombotic Thrombocytopenic Purpura. Southern Medical Journal. 81(1). 81–83. 2 indexed citations
18.
Doolittle, Gary C., et al.. (1988). Malignancy-Induced Lactic Acidosis. Southern Medical Journal. 81(4). 533–536. 19 indexed citations
19.
Bodensteiner, David. (1988). Book ReviewBlood Transfusion Therapy: A problem-oriented approach White Cells and Platelets in Blood Transfusion. New England Journal of Medicine. 318(22). 1479–1479. 2 indexed citations
20.
Bodensteiner, David, et al.. (1983). Profound Neutropenia Associated With Benzylpenicillin. Southern Medical Journal. 76(10). 1299–1301. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by U. Jehn Breakdown of academic impact, for papers by Hamdi Akan Breakdown of academic impact, for papers by Martin Schmidt‐Hieber Breakdown of academic impact, for papers by Subhash Varma Breakdown of academic impact, for papers by Anna Candoni Breakdown of academic impact, for papers by Steve Trifilio Breakdown of academic impact, for papers by Gloria Mattiuzzi Breakdown of academic impact, for papers by Lambert F. R. Span Breakdown of academic impact, for papers by Nicole M. A. Blijlevens Breakdown of academic impact, for papers by Carola Arndt
Rankless by CCL
2026